Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline setbacks. In August 2025, Vertex’s phase II study on the oral formulation of ...

Forget what you think you know. Our lab tests reveal surprising links between battery life, price, suction and weight.

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

These students will be eligible to appear for the board examinations scheduled to be held in February/March/April 2026, alongside regular candidates Students who passed in 2025 but wish to improve ...

The Central Board of Secondary Education (CBSE) has released a detailed notification regarding key activities for the 2026 board examinations. The Board has urged affiliated schools to adhere strictly ...

Find the best ChatGPT alternatives in 2025. Compare Perplexity AI, Claude, Gemini, Abacus.ai, and Copilot for research, ...

Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release third quarter 2025 financial results before the market opens on Monday, ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” third-quarter ...

Vertex Pharmaceuticals Inc. closed 22.25% short of its 52-week high of $519.88, which the company reached on November 8th.

Hello, today I’m going to review the Particle Tachyon SBC designed for high-performance edge AI, IoT, and connectivity ...

Back in 1993, WIRED’s founders published a manifesto offering some guidance. “Our first instruction to our writers: Amaze us … tell us something we've never heard before, in a way we've never seen ...